Matica Bio designates Paul Kim as CEO

Paul Kim, Matica Bio's new CEO

Matica Biotechnology, Inc., a contract development and manufacturing organization (CDMO) of cell and gene therapies (CGTs), yesterday announced the appointment of Paul Kim as chief executive officer (CEO). As incoming CEO, Kim will manage daily operations and provide strategic direction to Matica Bio as it rapidly expands its capacity and capabilities in the U.S. and […]

Mytide Therapeutics announces leadership transition

Mytide, the tech-enabled biotechnology manufacturing services company, recently announced the appointment of Dr. Martina Diekmann as Chief Executive Officer. She will take over as CEO from Mytide’s founder Dale Thomas, who has served as the company’s CEO since 2018. Following Dr. Diekmann’s appointment, Thomas will assume the role of Chief Technology Officer and focus on […]